These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 23185023

  • 1. Polymer-attached zanamivir inhibits synergistically both early and late stages of influenza virus infection.
    Lee CM, Weight AK, Haldar J, Wang L, Klibanov AM, Chen J.
    Proc Natl Acad Sci U S A; 2012 Dec 11; 109(50):20385-90. PubMed ID: 23185023
    [Abstract] [Full Text] [Related]

  • 2. A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.
    Tarbet EB, Hamilton S, Vollmer AH, Luttick A, Ng WC, Pryor M, Hurst BL, Crawford S, Smee DF, Tucker SP.
    J Antimicrob Chemother; 2014 Aug 11; 69(8):2164-74. PubMed ID: 24777908
    [Abstract] [Full Text] [Related]

  • 3. In Vitro and In Vivo Characterization of Novel Neuraminidase Substitutions in Influenza A(H1N1)pdm09 Virus Identified Using Laninamivir-Mediated In Vitro Selection.
    Lloren KKS, Kwon JJ, Choi WS, Jeong JH, Ahn SJ, Choi YK, Baek YH, Song MS.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30602610
    [Abstract] [Full Text] [Related]

  • 4. Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus.
    Weight AK, Haldar J, Alvarez de Cienfuegos L, Gubareva LV, Tumpey TM, Chen J, Klibanov AM.
    J Pharm Sci; 2011 Mar 15; 100(3):831-5. PubMed ID: 20740680
    [Abstract] [Full Text] [Related]

  • 5. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
    Neri-Bazán RM, García-Machorro J, Méndez-Luna D, Tolentino-López LE, Martínez-Ramos F, Padilla-Martínez II, Aguilar-Faisal L, Soriano-Ursúa MA, Trujillo-Ferrara JG, Fragoso-Vázquez MJ, Barrón BL, Correa-Basurto J.
    Eur J Med Chem; 2017 Mar 10; 128():154-167. PubMed ID: 28182988
    [Abstract] [Full Text] [Related]

  • 6. Enhanced anti-influenza agents conjugated with anti-inflammatory activity.
    Liu KC, Fang JM, Jan JT, Cheng TJ, Wang SY, Yang ST, Cheng YS, Wong CH.
    J Med Chem; 2012 Oct 11; 55(19):8493-501. PubMed ID: 22963087
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
    Ikematsu H, Kawai N, Iwaki N, Kashiwagi S.
    J Infect Chemother; 2014 Feb 11; 20(2):77-80. PubMed ID: 24560563
    [Abstract] [Full Text] [Related]

  • 9. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
    Cheng CK, Tsai CH, Shie JJ, Fang JM.
    Future Med Chem; 2014 May 11; 6(7):757-74. PubMed ID: 24941871
    [Abstract] [Full Text] [Related]

  • 10. Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models.
    Saito M, Itoh Y, Yasui F, Munakata T, Yamane D, Ozawa M, Ito R, Katoh T, Ishigaki H, Nakayama M, Shichinohe S, Yamaji K, Yamamoto N, Ikejiri A, Honda T, Sanada T, Sakoda Y, Kida H, Le TQM, Kawaoka Y, Ogasawara K, Tsukiyama-Kohara K, Suga H, Kohara M.
    Nat Commun; 2021 May 11; 12(1):2654. PubMed ID: 33976181
    [Abstract] [Full Text] [Related]

  • 11. Anti-influenza activity of Alchemilla mollis extract: possible virucidal activity against influenza virus particles.
    Makau JN, Watanabe K, Kobayashi N.
    Drug Discov Ther; 2013 Oct 11; 7(5):189-95. PubMed ID: 24270383
    [Abstract] [Full Text] [Related]

  • 12. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
    Lee BW, Ha TKQ, Cho HM, An JP, Kim SK, Kim CS, Kim E, Oh WK.
    J Ethnopharmacol; 2020 Sep 15; 259():112945. PubMed ID: 32389854
    [Abstract] [Full Text] [Related]

  • 13. [In vitro and in vivo effects of a long-acting anti-influenza agent CS-8958 (laninamivir octanoate, Inavir) against pandemic (H1N1) 2009 influenza viruses].
    Kubo S, Kakuta M, Yamashita M.
    Jpn J Antibiot; 2010 Oct 15; 63(5):337-46. PubMed ID: 21268406
    [Abstract] [Full Text] [Related]

  • 14. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.
    Hurt AC, Holien JK, Parker M, Kelso A, Barr IG.
    J Virol; 2009 Oct 15; 83(20):10366-73. PubMed ID: 19641000
    [Abstract] [Full Text] [Related]

  • 15. Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
    Kubo S, Tomozawa T, Kakuta M, Tokumitsu A, Yamashita M.
    Antimicrob Agents Chemother; 2010 Mar 15; 54(3):1256-64. PubMed ID: 20047917
    [Abstract] [Full Text] [Related]

  • 16. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
    Ikematsu H, Kawai N, Iwaki N, Kashiwagi S.
    J Infect Chemother; 2015 Jan 15; 21(1):39-42. PubMed ID: 25277670
    [Abstract] [Full Text] [Related]

  • 17. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    Kwon JJ, Choi WS, Jeong JH, Kim EH, Lee OJ, Yoon SW, Hwang J, Webby RJ, Govorkova EA, Choi YK, Baek YH, Song MS.
    J Gen Virol; 2018 Mar 15; 99(3):292-302. PubMed ID: 29493493
    [Abstract] [Full Text] [Related]

  • 18. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H, Kawai N.
    Expert Rev Anti Infect Ther; 2011 Oct 15; 9(10):851-7. PubMed ID: 21973296
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
    Wang H, Xu R, Shi Y, Si L, Jiao P, Fan Z, Han X, Wu X, Zhou X, Yu F, Zhang Y, Zhang L, Zhang L, Zhou D, Xiao S.
    Eur J Med Chem; 2016 Mar 03; 110():376-88. PubMed ID: 26866456
    [Abstract] [Full Text] [Related]

  • 20. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T, Bahl J, Marathe BM, Culhane M, Stigger-Rosser E, Darnell D, Kaplan BS, Lowe JF, Webby RJ, Govorkova EA.
    Antiviral Res; 2015 May 03; 117():10-9. PubMed ID: 25701593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.